Ifpma

Edit

A better global health architecture delivers both innovation and access (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 12 Feb 2026

[...] ... IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on February 12, 2026, and is solely responsible for the information contained herein.

Edit

Statement at the fifth meeting of the open-ended Intergovernmental Working Group (IGWG 5) on the WHO Pandemic Agreement (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 09 Feb 2026

IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on February 09, 2026, and is solely responsible for the information contained herein.

Edit

158th session of the WHO Executive Board (EB158): Reform of the global health architecture and the UN80 initiative (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 06 Feb 2026

On 6 February 2026, IFPMA delivered a statement on Agenda item 29.1 on reform of the global health architecture at the 158th session of the WHO Executive Board in Geneva ... About IFPMA ... ifpma.org ... Elliot Dunster [email protected].

Edit

158th session of the WHO Executive Board: Substandard and falsified medical products (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 04 Feb 2026

On 4 February 2026, IAPO delivered a statement on Agenda item 12 on substandard and falsified medical products at the 158th session of the WHO Executive Board on behalf of the Fight the Fakes Alliance, of which IFPMA is a member.

Edit

158th session of the WHO Executive Board: WHO’s work in health emergencies (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 04 Feb 2026

) ... Across the EB158 agenda, one theme stands out ... IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on February 04, 2026, and is solely responsible for the information contained herein ... (noodl.

Edit

158th session of the WHO Executive Board (EB158): Harmonization of regulatory approaches, governance, and standards for data, digital health, and artificial intelligence in the health sector (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 04 Feb 2026

About IFPMA. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations ... ifpma.org ... Elliot Dunster [email protected].

Edit

158th session of the WHO Executive Board (EB158): Draft updated global action plan on antimicrobial resistance (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 04 Feb 2026

On 4 February 2026, IFPMA delivered a statement on Agenda item 14 on the draft updated global action plan on antimicrobial resistance (AMR) at the 158th session of the WHO Executive Board ... About IFPMA ... ifpma.org ... Elliot Dunster [email protected].

Edit

158th session of the WHO Executive Board (EB158): Co-creating the Global Action Plan for rare diseases (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 03 Feb 2026

On 3 February 2026, IFPMA delivered a statement on Agenda item 9 ... About IFPMA. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations.

Edit

158th session of the WHO Executive Board (EB158): Priorities for financing noncommunicable diseases to achieve universal health coverage (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 02 Feb 2026

) ... a joint statement BY. ... Disclaimer. IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on February 02, 2026, and is solely responsible for the information contained herein ... (noodl. 129227316) .

Edit

The innovation development and access pathway: A holistic approach to accelerating access to innovative medicines and vaccines (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 12 Dec 2025

) ... This is particularly acute in lower-resource settings ... IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on December 12, 2025, and is solely responsible for the information contained herein.

Edit

A new dawn in global health: UHC as the path toward national health stewardship (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 11 Dec 2025

[...] ... Disclaimer. IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on December 12, 2025, and is solely responsible for the information contained herein.

Edit

Statement at the fourth meeting of the open-ended Intergovernmental Working Group (IGWG 4) on the WHO Pandemic Agreement (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 01 Dec 2025

On 1st December 2025 in Geneva, IFPMA delivered a statement at at the fourth meeting of the open-ended Intergovernmental Working Group (IGWG 4) on the WHO Pandemic Agreement ... IFPMA - International ...

Edit

Considerations on the use of reliance in clinical trials review (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 25 Nov 2025

) ... Attachments Original document Permalink. Disclaimer. IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on November 25, 2025, and is solely responsible for the information contained herein.

Edit

WIPO Committee on IP and Development (CDIP 35): Technology Transfer (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 21 Nov 2025

On 20 November 2025, IFPMA submitted a statement on technology transfer at the WIPO Committee on IP and Development (CDIP 35) in Geneva ... About IFPMA ... ifpma.org ... Elliot Dunster [email protected].

Edit

Health as an economic priority – building on momentum driven by the G20 South Africa Presidency (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 17 Nov 2025

IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on November 17, 2025, and is ...

Podcasts:

Latest News for: ifpma

A better global health architecture delivers both innovation and access (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Statement at the fifth meeting of the open-ended Intergovernmental Working Group (IGWG 5) on the WHO Pandemic Agreement (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

158th session of the WHO Executive Board (EB158): Reform of the global health architecture and the UN80 initiative (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

158th session of the WHO Executive Board: Substandard and falsified medical products (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

158th session of the WHO Executive Board: WHO’s work in health emergencies (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

158th session of the WHO Executive Board (EB158): Harmonization of regulatory approaches, governance, and standards for data, digital health, and artificial intelligence in the health sector (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

158th session of the WHO Executive Board (EB158): Draft updated global action plan on antimicrobial resistance (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

158th session of the WHO Executive Board (EB158): Co-creating the Global Action Plan for rare diseases (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

158th session of the WHO Executive Board (EB158): Priorities for financing noncommunicable diseases to achieve universal health coverage (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

The innovation development and access pathway: A holistic approach to accelerating access to innovative medicines and vaccines (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

A new dawn in global health: UHC as the path toward national health stewardship (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Statement at the fourth meeting of the open-ended Intergovernmental Working Group (IGWG 4) on the WHO Pandemic Agreement (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Considerations on the use of reliance in clinical trials review (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

WIPO Committee on IP and Development (CDIP 35): Technology Transfer (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Health as an economic priority – building on momentum driven by the G20 South Africa Presidency (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Article Search

EXPLORE WN.com